Last reviewed · How we verify

Acetylsalicylzuur Apotex Cardio — Competitive Intelligence Brief

Acetylsalicylzuur Apotex Cardio (Acetylsalicylzuur Apotex Cardio) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: NSAID. Area: Cardiovascular.

phase 1 NSAID COX-1 and COX-2 Cardiovascular Small molecule Live · refreshed every 30 min

Target snapshot

Acetylsalicylzuur Apotex Cardio (Acetylsalicylzuur Apotex Cardio) — AstraZeneca. Inhibits COX-1 and COX-2 enzymes

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Acetylsalicylzuur Apotex Cardio TARGET Acetylsalicylzuur Apotex Cardio AstraZeneca phase 1 NSAID COX-1 and COX-2
Cytotec Misoprostol Pfizer marketed NSAID combined with prostaglandin analog Cyclooxygenase (COX-1 and COX-2); Prostaglandin receptors 1988-01-01
Ibuprofen Tablets Ibuprofen Tablets Overseas Pharmaceuticals, Ltd. marketed Nonsteroidal anti-inflammatory drug (NSAID) COX-1 and COX-2
Metamizole and Ibuprofen Metamizole and Ibuprofen University Hospital, Basel, Switzerland marketed Nonsteroidal anti-inflammatory drug (NSAID) combination Cyclooxygenase (COX-1 and COX-2)
ketorolac tromethamine 0.4% ketorolac tromethamine 0.4% Clinica Oftamologica Zona Sul marketed Nonsteroidal anti-inflammatory drug (NSAID) Cyclooxygenase (COX-1 and COX-2)
ACULAR ACULAR University of South Alabama marketed NSAID (nonsteroidal anti-inflammatory drug) COX-1 and COX-2
Loxoprofen sodium hydrogel patch Loxoprofen sodium hydrogel patch Sun Yat-sen University marketed Nonsteroidal anti-inflammatory drug (NSAID) Cyclooxygenase (COX-1 and COX-2)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (NSAID class)

  1. Antibe Therapeutics Inc. · 3 drugs in this class
  2. Iroko Pharmaceuticals, LLC · 3 drugs in this class
  3. Organon and Co · 2 drugs in this class
  4. Apsen Farmaceutica S.A. · 2 drugs in this class
  5. Amneal Pharmaceuticals, LLC · 2 drugs in this class
  6. Behar, Caren, M.D. · 2 drugs in this class
  7. IDEA AG · 2 drugs in this class
  8. Noven Pharmaceuticals, Inc. · 2 drugs in this class
  9. HALEON · 2 drugs in this class
  10. Pfizer · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Acetylsalicylzuur Apotex Cardio — Competitive Intelligence Brief. https://druglandscape.com/ci/acetylsalicylzuur-apotex-cardio. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators: